Literature DB >> 32442990

Skin dose in chest wall radiotherapy with bolus: a Monte Carlo study.

Patricia A K Oliver1, Thalat Theresa Monajemi2.   

Abstract

Monte Carlo simulations are used to investigate skin dose resulting from chest wall radiotherapy with bolus. A simple model of a female thorax is developed, which includes a 2 mm-thick skin layer. Two representative 6 MV source models are considered: a tangents source model consisting of a parallel opposed pair of medial and lateral fields and subfields, and an arc source model. Tissue equivalent (TE) boluses (thicknesses of 3, 5 and 10 mm) and brass mesh bolus are considered. Skin dose distributions depend on incident photon obliquity: for tangents, radiation is incident more obliquely, resulting in longer path lengths through the bolus and higher skin dose compared to the arc source model in most cases. However, for thicker TE boluses, attenuation of oblique photons becomes apparent. Brass bolus and 3 mm TE bolus result in similar mean skin dose. This relatively simple computational model allows for consideration of different bolus thicknesses, materials and usage schedules based on desired skin dose and choice of either tangents or an arc beam technique. For example, using a 5 mm TE bolus every second treatment would result in mean skin doses of 89% and 85% for tangents and the arc source model, respectively. The hot spot metric D0.01ccwould be 103% and 99%, respectively.
© 2020 Institute of Physics and Engineering in Medicine.

Entities:  

Keywords:  Monte Carlo; bolus; chest wall radiotherapy; skin dose

Year:  2020        PMID: 32442990     DOI: 10.1088/1361-6560/ab95dc

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  1 in total

1.  Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trial.

Authors:  Youness Nour; Christoph Pöttgen; Sied Kebir; Lazaros Lazaridis; Lutz Lüdemann; Maja Guberina; Thomas Gauler; Björn Scheffler; Ramazan Jabbarli; Daniela Pierscianek; Ulrich Sure; Teresa Schmidt; Christoph Oster; Peter Hau; Martin Glas; Wolfgang Lübcke; Martin Stuschke; Nika Guberina
Journal:  J Appl Clin Med Phys       Date:  2021-01-03       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.